Oxygen Always is very familiar with ResMed Inc., who is a leading maker of breathing aids for people who suffer from sleep apnea. It came as no surprise to the retailers of portable oxygen concentrators when ResMed announced that they had agreed to buy privately held Inova Labs in an effort to expand their oxygen therapy offerings for chronic lung disease patients.
While the terms of the deal were not fully disclosed, ResMed’s chief executive stated that they speculated the Inova products could potentially add $500 million in annual sales. ResMed’s current annual revenue is approximately $1.7 billion. If they are able execute their plans, they could easily make turn the business into a half a billion dollar business within the next five to ten years.
Approximately 65 million people suffer from moderate to severe COPD, the number 3 killer in the United States, which is primarily caused by smoking. ResMed claims that they were interested in breaching into the realm of oxygen concentrators because they admire the light, mobile, and longevity of the battery life in these devices that give freedom back to the patients they serve.
Oxygen Always knows that ResMed has great intentions and a great deal to offer Inova. ResMed envisions eventually adding a computer chip to the Inova portable oxygen concentrators so that doctors are able to remotely monitor the patient’s breathing, just as it has done for their sleep apnea equipment.
Recent Comments